John Sigurd Mjøen Svendsen
Fondateur chez Pharmasum Therapeutics AS
Profil
John Sigurd Mjøen Svendsen is the founder of Lytix Biopharma AS, which was founded in 2003.
He held the title of Board Member & Director-Discovery Research from 2012 to 2013.
Dr. Svendsen is also the founder of Pharmasum Therapeutics AS.
Currently, he is a Professor at the University of Tromso.
In the past, he worked as a Director at Prophylix AS and as a Professor at the Massachusetts Institute of Technology.
Dr. Svendsen obtained a doctorate degree from the University of Tromso.
Postes actifs de John Sigurd Mjøen Svendsen
| Sociétés | Poste | Début |
|---|---|---|
| University of Tromso | Corporate Officer/Principal | 14/05/2009 |
Pharmasum Therapeutics AS
 Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | Fondateur | - |
Anciens postes connus de John Sigurd Mjøen Svendsen
| Sociétés | Poste | Fin |
|---|---|---|
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Directeur/Membre du Conseil | - |
| Massachusetts Institute of Technology | Corporate Officer/Principal | - |
| LYTIX BIOPHARMA | Fondateur | - |
Formation de John Sigurd Mjøen Svendsen
| University of Tromso | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| LYTIX BIOPHARMA | Health Technology |
| Entreprise privées | 2 |
|---|---|
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Health Technology |
Pharmasum Therapeutics AS
Pharmasum Therapeutics AS BiotechnologyHealth Technology Pharmasum Therapeutics AS operates as a pharmaceutical company. The firm focuses on the discovery and development of novel human medicines for the treatment of brain diseases, especially neurological diseases. The company was founded by Anders Fugelli and John Sigurd Svendsen is headquartered in Kvaloysletta, Norway. | Health Technology |
